Secondaries announced 8.17.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Eiger BioPharmaceuticals, Inc.
Symbol: EIGR
Price: Last trade $17.19
Description: Re-offer range $16.00-$16.50
Trade Date: 8/18
Shares: 1.16 million
Underwriter(s) JefferiesCo Manager(s) Oppenheimer & Co., Wedbush PacGrow
Rating=Subscription Needed

Company: OncoMed Pharmaceuticals, Inc.
Symbol: OMED
Price: Last trade $11.71
Trade Date: 8/18
Shares: 4.3 million
Underwriter(s) Leerink Partners
Rating=Subscription Needed